India’s Drug Regulator Expedites Introduction of Advanced Therapeutics
In a recent move to bring advanced therapeutics to India, the Drug Controller General of India (DCGI), who heads the
Pharma
Validating COVAXIN Safety: BHU Study and ICMR Critique
The Banarus Hindu University (BHU), in its recent publication with Drug Safety (a Springer Journal), reported long-term adverse events of
AstraZeneca withdraws Covid-19 vaccine and admits to rare side effects
In May, AstraZeneca retracted the marketing authorization for its COVID-19 vaccine due to commercial reasons. This decision followed months after